Follow
HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization. (arXiv:2111.04738v1 [q-bio.QM]) http://arxiv.org/abs/2111.04738
HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization. (arXiv:2111.04738v1 [q-bio.QM]) http://arxiv.org/abs/2111.04738